FERINJECT 50mg / ml injectable/perfusable dispersion medication leaflet

B03AC01 • iron carboxymaltose • Blood and blood forming organs | Iron preparations | Iron, parenteral preparations

Ferric carboxymaltose is a medication used to treat iron deficiency and iron deficiency anemia, especially in patients who cannot tolerate or do not respond to oral iron therapy. It is administered intravenously and allows for the rapid replenishment of the body's iron stores, helping to improve symptoms such as fatigue, weakness, and difficulty concentrating.

The administration of ferric carboxymaltose is done under medical supervision, with the dose determined based on the individual's iron needs and the severity of the anemia. Treatment may require one or more infusions, and careful monitoring of the patient is essential to prevent adverse reactions.

Side effects may include reactions at the injection site, nausea, headaches, dizziness, or a temporary increase in liver transaminase levels. In rare cases, severe allergic reactions or a sudden drop in blood pressure may occur. Any unusual symptoms should be reported to the doctor immediately.

Ferric carboxymaltose is an effective option for the rapid correction of iron deficiency, but its use requires careful medical monitoring. Following the doctor's instructions and being informed about possible side effects contribute to safe and effective treatment.